about
Molecular mechanisms and regulation of urinary acidificationGenetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasisMolecular and functional analysis of SDCT2, a novel rat sodium-dependent dicarboxylate transporterMutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delayCitrate anticoagulation: Are blood donors donating bone?Water and other fluids in nephrolithiasis: State of the art and future challenges.Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?Renal citrate metabolism and urinary citrate excretion in the infant rat.Direct evidence for calcineurin binding to the exon-7 loop of the sodium-bicarbonate cotransporter NBCn1.Comprehensive analysis of citrate effects during plateletpheresis in normal donors.Urinary citrate excretion in healthy children depends on age and gender.Proximal tubule function and response to acidosis.Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human populationMolecular properties of the SLC13 family of dicarboxylate and sulfate transportersCalcium sensitivity of dicarboxylate transport in cultured proximal tubule cells.Knowledge, attitudes, and practice patterns among healthcare providers in the prevention of recurrent kidney stones in Northern OntarioAssociations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.Synthesis, maturation, and trafficking of human Na+-dicarboxylate cotransporter NaDC1 requires the chaperone activity of cyclophilin B.High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric KidneysUrinary 1H-NMR metabolomics can distinguish pancreatitis patients from healthy controls.Type 2 diabetes mellitus and renal stonesCalcium oxalate crystal related kidney injury in a patient receiving Roux-en Y hepaticojejunostomy due to gall bladder cancerTopiramate for the treatment of epilepsy and other nervous system disorders.Metabolic syndrome and nephrolithiasis.Effect of NBCe1 deletion on renal citrate and 2-oxoglutarate handling.Dietary and lifestyle factors and medical conditions associated with urinary citrate excretionAdenosine triphosphate citrate lyase mediates hypocitraturia in rats.Diabetic severity and risk of kidney stone disease.Can acetazolamide be used to treat diseases involving increased bone mineral density?1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease.Clinical approach to renal tubular acidosis in adult patients.An update on primary hyperoxaluria.Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions.Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family.Safety Assessment of Citric Acid, Inorganic Citrate Salts, and Alkyl Citrate Esters as Used in Cosmetics.Salt and nephrolithiasis.The management of patients with enteric hyperoxaluria.The urine metabolome differs between lean and overweight Labrador Retriever dogs during a feed-challenge.Ammonia Transporters and Their Role in Acid-Base Balance.
P2860
Q26823086-4135E1B5-D3FF-439A-A662-0C03B055455FQ28505771-816526D0-AE35-4C9D-A3CD-D7C5BA58C50EQ28583210-BE9CFFF1-7FB3-4A10-9D65-86B15600D393Q28830248-86C1A635-C0D7-41F4-9D9B-5E84B31215A2Q30252024-C542C7A1-BD4E-4C7E-83E3-021BF4D559A2Q30252153-EC6D8C68-F53D-427D-9C9E-51E01BB16C41Q33226031-3360A32B-5641-4914-8AB0-F8F9E0DC77FFQ33873799-FE17035D-2551-42B6-ADCC-EC1385C55044Q33970173-642A9B3E-0622-4851-A657-F0D3BCB129A3Q34090886-2AB0E28C-7F12-4770-B518-484844E181D5Q34100411-C06DD6F1-B100-455B-BCCB-B93ADD9C59AAQ34124765-657AAAE8-C62C-4272-B95C-F92B538B3CAFQ34265048-E535CE9B-1E22-4D4C-8A90-DD4E8AFB8E7BQ34309405-A4D71F59-933D-44C8-9573-F7B34BC5194AQ34457752-AAD5FA2F-6438-47E0-A4E6-4625384B4ABFQ34599822-18C5A35C-A6ED-4A09-B462-8F88DA632B5BQ34602128-5125D9F2-1C29-4640-B11A-6A5E214D9B8CQ34624253-49BEB914-8DD8-466D-8966-860C6941B94BQ34719586-B52BC473-E674-4DD4-A67A-7F8CF2290B18Q35737408-4E3D25EC-6994-451F-A75A-3D70D476E8FEQ35847733-1BCEA20C-AE7B-4FA0-98D2-97ED804FFD4AQ36196901-E3B8CFF5-393F-423B-BF6A-4E7FA2D534A2Q36327251-63EE3AD8-F256-4CEB-BF66-A3251ABDAD38Q36390841-99A7A2B2-1E7E-4BB1-BE7A-AE5ECDDA2545Q36451152-FA5D7C02-C2CA-4DCD-B559-908E37E7D10BQ36846453-352A452F-4B64-48FE-AF21-27721DE90F01Q36910910-E9FF42C8-5565-46F7-983E-BFC11B59A4C8Q37361606-BDE69E17-1735-4EBA-BE2E-6DDC17A5E2A8Q37400997-CF926A1A-740B-4256-9572-1A7AA44700DEQ37425297-228680ED-FCBD-4AA7-BDD2-B8A7E1F24A1BQ37495723-5EB7FD53-EBE9-448C-8906-5B23572E90E4Q37840276-C1ED6C1E-C293-4A45-8AC6-46629E9E4E38Q38017938-E54FF60A-8E7C-40C8-8021-E6C028414FD6Q38061207-2B59C577-EB1D-47A5-937A-8D14148AAEFEQ38151505-11DB5DAD-31D5-45B0-9FBF-E3800FA8BE88Q38214850-4003A72C-FD47-4ADE-9C54-0AB5C3F504F7Q38230324-2CA9C346-49D6-4FA8-9815-D47408925887Q38662272-119E73BA-0588-44BC-BED7-A0F887104858Q38702324-7DED1BCC-54CC-4741-B546-744231FD5481Q39115255-5DA4D8A7-F635-43F2-84AE-B31DC01CED61
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Renal handling of citrate.
@en
Renal handling of citrate.
@nl
type
label
Renal handling of citrate.
@en
Renal handling of citrate.
@nl
prefLabel
Renal handling of citrate.
@en
Renal handling of citrate.
@nl
P356
P1433
P1476
Renal handling of citrate.
@en
P2093
P2888
P304
P356
10.1038/KI.1990.265
P407
P577
1990-10-01T00:00:00Z